- We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred in the 10 patients.
- Publication status:
- Publisher copy:
- Movement disorders : official journal of the Movement Disorder Society
- Publication date:
- Source identifiers:
- Local pid:
- Copyright date:
A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record